Their innovative tool, Noratest®, is the first blood-based diagnosis of Alzheimer's disease available at the onset of the first symptoms with a medical prescription. It is a French biotechnology company specializing in developing diagnostic solutions for Alzheimer's disease. Noratest® can discriminate patients with Alzheimer's disease from those with other neurodegenerative diseases, making it easier for the medical industry to detect Alzheimer's disease. The product has received the CE IVD mark, indicating its compliance with European Union regulations.